CLINICAL_TRIALS
research
· 2020-11-02
Clinical Trial Update: Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease
Summary
A completed clinical trial evaluating cardiac MRI to define a specific restrictive cardiomyopathy in patients with sickle cell disease; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Disease | Status: COMPLETED | Results posted: 2020-11-02